U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Novoeight
  1. Approved Blood Products

STN: BL 125466
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: Novoeight
Manufacturer: Novo Nordisk 

Indication: 

  • For adults, adolescents, and children with hemophilia A for (1) the control and prevention of bleeding episodes, (2) perioperative management, and (3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Product Information

Supporting Document

Back to Top